These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 6430708)
21. Unusual expression of IL 2 receptors and both the c-myb and c-raf oncogenes in T cell lines and clones derived from autoimmune MRL-lpr/lpr mice. Rosenberg YJ; Malek TR; Schaeffer DE; Santoro TJ; Mark GE; Steinberg AD; Mountz JD J Immunol; 1985 May; 134(5):3120-3. PubMed ID: 3920313 [TBL] [Abstract][Full Text] [Related]
22. Antigen-specific T-cell hyporesponsiveness in MRL congenic mice can be explained by two independent cellular defects. Waterfield JD; Fairhurst M; Chu R; Levy JG Immunology; 1987 Jun; 61(2):173-8. PubMed ID: 2954899 [TBL] [Abstract][Full Text] [Related]
23. Unique surface phenotype of T cells in lymphoproliferative autoimmune MRL/Mp-lpr/lpr mice. Takei F J Immunol; 1984 Oct; 133(4):1951-4. PubMed ID: 6332141 [TBL] [Abstract][Full Text] [Related]
24. Signals required for activation and growth of autoimmune T lymphocytes. Santoro TJ; Malek TR; Rosenberg YJ; Morse HC; Steinberg AD J Mol Cell Immunol; 1984; 1(6):347-56. PubMed ID: 6086044 [TBL] [Abstract][Full Text] [Related]
25. Autoimmune MRL/lpr mice sera contain IgG with interleukin 3-like activity. Ohta Y; Tamura S; Tezuka E; Sugawara M; Imai S; Tanaka H J Immunol; 1988 Jan; 140(2):520-5. PubMed ID: 3257242 [TBL] [Abstract][Full Text] [Related]
26. Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions. Jabs DA; Enger C; Prendergast RA Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):371-80. PubMed ID: 1993589 [TBL] [Abstract][Full Text] [Related]
27. CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production. Mountz JD; Smith HR; Wilder RL; Reeves JP; Steinberg AD J Immunol; 1987 Jan; 138(1):157-63. PubMed ID: 3537128 [TBL] [Abstract][Full Text] [Related]
28. Expression of a bone marrow-associated Ly-6 determinant on the T cell population expanding in the lymph nodes of the autoimmune mouse strain MRL/Mp-lpr/lpr. Melino MR; Dumont FJ; Habbersett RC; Hansen TH J Immunol; 1983 Apr; 130(4):1843-7. PubMed ID: 6601141 [TBL] [Abstract][Full Text] [Related]
29. Stimulation of murine T cells via the Ly-6C antigen: lack of proliferative response in aberrant T cells from lpr/lpr and gld/gld mice despite high Ly-6C antigen expression. Dumont FJ J Immunol; 1987 Jun; 138(12):4106-13. PubMed ID: 2438334 [TBL] [Abstract][Full Text] [Related]
30. In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse. Murray LJ; Lee R; Martens C Eur J Immunol; 1990 Jan; 20(1):163-70. PubMed ID: 1968391 [TBL] [Abstract][Full Text] [Related]
31. Responses of B cells from autoimmune mice to IL-5. Umland SP; Go NF; Cupp JE; Howard M J Immunol; 1989 Mar; 142(5):1528-35. PubMed ID: 2783944 [TBL] [Abstract][Full Text] [Related]
32. Interleukin-2 induction, response and therapy on murine lupus lesions in the MRL/l strain. Abe C; Koyama A; Nishimura T Prog Clin Biol Res; 1987; 229():147-56. PubMed ID: 3496609 [TBL] [Abstract][Full Text] [Related]
33. Interleukin 2 responses of lpr and normal L3T4-/Lyt-2- T cells induced by TPA plus A23187. Katagiri K; Katagiri T; Eisenberg RA; Ting J; Cohen PL J Immunol; 1987 Jan; 138(1):149-56. PubMed ID: 3097142 [TBL] [Abstract][Full Text] [Related]
34. Oncogene expression in autoimmune mice. Mountz JD; Mushinski JF; Mark GE; Steinberg AD J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923 [TBL] [Abstract][Full Text] [Related]
35. Increased cell surface expression of a newly identified heterodimer on activated blastic T cells. Nagata N; Taketani S; Nakagawa T; Hosaka N; Hisha H; Tokunaga R; Ikehara S Cell Immunol; 1994 Feb; 153(2):516-26. PubMed ID: 8118879 [TBL] [Abstract][Full Text] [Related]
36. Defective T cell response to presented antigen in autoimmune mice. Fischbach M J Immunol; 1984 Nov; 133(5):2365-8. PubMed ID: 6332846 [TBL] [Abstract][Full Text] [Related]
37. Subsets of Lyt-2+ cells defined by differential expression of the 9F3 antigen: alterations in mice of the lpr/lpr genotype. Dumont FJ; Habbersett RC; Coker LZ J Immunol; 1985 Jan; 134(1):196-203. PubMed ID: 3880569 [TBL] [Abstract][Full Text] [Related]
38. IL-2 receptor expression in autoimmune MRL-lpr/lpr mice. The expanded L3T4-, Lyt-2- population does not express p75 and cannot generate functional high-affinity IL-2 receptors. Rosenberg YJ; Nurse F; Begley CG J Immunol; 1989 Oct; 143(7):2216-22. PubMed ID: 2789257 [TBL] [Abstract][Full Text] [Related]
39. [A study on the mechanism of activation of peritoneal exudate macrophages from MRL/MpJ-lpr/lpr mice]. Hashimoto Y Hokkaido Igaku Zasshi; 1988 Sep; 63(5):781-90. PubMed ID: 2853694 [TBL] [Abstract][Full Text] [Related]
40. Unusual cell surface properties of the T lymphocyte population expanding in MRL/Mp-lpr/lpr mice. Dumont F; Habbersett RG Immunology; 1982 Oct; 47(2):271-81. PubMed ID: 6981590 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]